Want to see IN:EXCELINDUS full AI Analyst Report?
Top Page
Excel Industries Limited
(EXCELINDUS)
Select Model
Select Model
Rating:72Outperform
Price Target:
₹1,254.00
▲(27.74% Upside)
Action:Upgraded
Date:08/20/26
The score is driven primarily by strong financial stability from an extremely low-leverage balance sheet, offset by volatility in earnings and cash generation (including slightly negative free cash flow in FY2026). Technically, the stock is in an uptrend above major moving averages with positive MACD, while valuation (P/E ~20, ~1.4% yield) is fair but not a major catalyst.
Positive Factors
Extremely Low Leverage
An almost debt-free balance sheet reduces interest and refinancing risk, giving Excel Industries greater resilience through cyclical demand and earnings volatility while preserving flexibility to fund operations and investment.
Negative Factors
Uneven Revenue Growth
The multi-year pattern shows inconsistent demand or operating conditions rather than a steady growth trajectory. Repeated revenue fluctuations can make capacity planning, resource allocation, and forward earnings visibility more difficult.
Read all positive and negative factors
Positive Factors
Negative Factors
Extremely Low Leverage
An almost debt-free balance sheet reduces interest and refinancing risk, giving Excel Industries greater resilience through cyclical demand and earnings volatility while preserving flexibility to fund operations and investment.
Read all positive factors
Excel Industries Limited (EXCELINDUS) vs. iShares MSCI India ETF (INDA)
Market Cap
₹13.32B
Dividend Yield1.3%
Average Volume (3M)429.00
Price to Earnings (P/E)18.3
Beta (1Y)1.10
Revenue Growth5.49%
EPS Growth-18.94%
CountryIN
Employees1,048
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)56.77
Shares Outstanding12,570,692
10 Day Avg. Volume192
30 Day Avg. Volume429
Financial Highlights & Ratios
PEG Ratio-1.19
Price to Book (P/B)0.60
Price to Sales (P/S)0.93
P/FCF Ratio-301.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Excel Industries Limited Business Overview & Revenue Model
Company Description
Established in 1941 and headquartered in Mumbai, India, Excel Industries Limited conducts business both domestically and internationally, focusing on the production and sale of a diverse array of chemicals, pharmaceutical precursors, and ecologica...
How the Company Makes Money
null...
Excel Industries Limited Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
90
Very Positive
Cash Flow
62
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.79B | 10.95B | 9.78B | 8.26B | 10.84B | 11.72B |
| Gross Profit | 3.67B | 3.23B | 4.72B | 2.98B | 4.52B | 2.91B |
| EBITDA | 1.25B | 1.37B | 1.49B | 577.24M | 1.40B | 2.47B |
| Net Income | 713.74M | 756.65M | 853.13M | 170.10M | 799.36M | 1.61B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 21.05B | 19.20B | 17.96B | 14.93B | 14.87B |
| Cash, Cash Equivalents and Short-Term Investments | 1.45B | 1.45B | 2.22B | 2.07B | 1.43B | 771.01M |
| Total Debt | 0.00 | 78.81M | 122.78M | 17.81M | 26.74M | 74.10M |
| Total Liabilities | -17.03B | 4.02B | 3.32B | 3.68B | 2.51B | 3.37B |
| Stockholders Equity | 17.03B | 17.03B | 15.89B | 14.27B | 12.42B | 11.49B |
Cash Flow | ||||||
| Free Cash Flow | -170.35M | -33.68M | 182.70M | 404.65M | 926.92M | 350.40M |
| Operating Cash Flow | 163.84M | 761.00M | 618.19M | 723.73M | 1.25B | 1.09B |
| Investing Cash Flow | 31.87M | -493.62M | -412.90M | -512.29M | -1.18B | -1.04B |
| Financing Cash Flow | -229.17M | -245.01M | -160.70M | -169.31M | -345.81M | -168.89M |
Excel Industries Limited Technical Analysis
Positive
981.65
Price Trends
968.12
Positive
957.52
Positive
946.41
Positive
Market Momentum
27.97
Positive
53.04
Neutral
46.45
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:EXCELINDUS, the sentiment is Positive. The current price of 981.65 is below the 20-day moving average (MA) of 1038.42, above the 50-day MA of 968.12, and above the 200-day MA of 946.41, indicating a bullish trend. The MACD of 27.97 indicates Positive momentum. The RSI at 53.04 is Neutral, neither overbought nor oversold. The STOCH value of 46.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:EXCELINDUS.
Excel Industries Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ₹13.32B | 18.32 | ― | 1.40% | 5.49% | -18.94% | |
69 Neutral | ₹105.54B | 47.46 | ― | 0.62% | 5.11% | 20.64% | |
63 Neutral | ₹76.06B | 38.51 | ― | 0.48% | 11.08% | 34.10% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ₹47.43B | 38.02 | ― | 0.16% | 5.47% | 24.88% | |
51 Neutral | ₹56.07B | 164.78 | ― | 0.05% | 18.00% | 3.85% | |
45 Neutral | ₹195.44B | 37.06 | ― | 0.20% | 27.05% | 124.16% |
* General Sector Average
IN:EXCELINDUS
Excel Industries Limited
1,043.50
-182.60
-14.89%
IN:AARTIIND
AARTI Industries Ltd
538.95
161.95
42.96%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
2,048.65
35.96
1.79%
IN:BALAMINES
Balaji Amines Limited
2,435.35
966.87
65.84%
IN:LXCHEM
Laxmi Organic Industries Ltd.
167.70
-37.90
-18.43%
IN:NEOGEN
Neogen Chemicals Ltd.
2,232.05
796.31
55.46%
Excel Industries Limited Corporate Events
Excel Industries closes insider trading window ahead of June-quarter results
Jun 26, 2026
Excel Industries Limited has notified stock exchanges that, in line with its code of conduct and SEBI’s insider trading regulations, it will close the trading window for designated persons and their immediate relatives from 1 July 2026 until...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.